相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is the amount of glow predicting the fire? Residual inflammatory risk after percutaneous coronary intervention
Alessandro Candreva et al.
EUROPEAN HEART JOURNAL (2022)
Association between C-Reactive Protein Velocity and Left Ventricular Function in Patients with ST-Elevated Myocardial Infarction
Ariel Banai et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Targeting cardiovascular inflammation: next steps in clinical translation
Patrick R. Lawler et al.
EUROPEAN HEART JOURNAL (2021)
High sensitivity C-reactive protein is associated with worse infarct healing after revascularized ST-elevation myocardial infarction
Christina Tiller et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study
Wolfgang Ries et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Association of C-Reactive Protein Velocity with Early Left Ventricular Dysfunction in Patients with First ST-Elevation Myocardial Infarction
Magdalena Holzknecht et al.
JOURNAL OF CLINICAL MEDICINE (2021)
C-reactive protein velocity predicts microvascular pathology after acute ST-elevation myocardial infarction
Magdalena Holzknecht et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Association of Myocardial Injury With Serum Procalcitonin Levels in Patients With ST-Elevation Myocardial Infarction
Martin Reindl et al.
JAMA NETWORK OPEN (2020)
Analyzing Medical Research Results Based on Synthetic Data and Their Relation to Real Data Results: Systematic Comparison From Five Observational Studies
Anat Reiner Benaim et al.
JMIR MEDICAL INFORMATICS (2020)
Fourth universal definition of myocardial infarction (2018)
Kristian Thygesen et al.
EUROPEAN HEART JOURNAL (2019)
C-reactive protein velocity and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention
David Zahler et al.
JOURNAL OF NEPHROLOGY (2019)
Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome
Kuan Ken Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up
Maarten Vanhaverbeke et al.
CLINICAL CARDIOLOGY (2018)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker et al.
LANCET (2018)
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions
Deborah N. Kalkman et al.
EUROPEAN HEART JOURNAL (2018)
Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction
Martin Reindl et al.
HEART (2017)
Acute kidney injury is associated with microvascular myocardial damage following myocardial infarction
Sebastian Johannes Reinstadler et al.
KIDNEY INTERNATIONAL (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction
Martin Reindl et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2017)
CRP velocity and short-term mortality in ST segment elevation myocardial infarction
Assi Milwidsky et al.
BIOMARKERS (2017)
Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study
Hans-Josef Feistritzer et al.
BMC CARDIOVASCULAR DISORDERS (2016)
Combined biomarker testing for the prediction of left ventricular remodelling in ST-elevation myocardial infarction
Sebastian Johannes Reinstadler et al.
OPEN HEART (2016)
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
Friedrich W. Mohr et al.
LANCET (2013)
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
Yaron Arbel et al.
ATHEROSCLEROSIS (2012)
B-cell targeted therapies in human autoimmune diseases: an updated perspective
Michael J. Townsend et al.
IMMUNOLOGICAL REVIEWS (2010)
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention
Paolo Ortolani et al.
EUROPEAN HEART JOURNAL (2008)
Comparison of values of wide-range C-reactive protein to high-sensitivity C-reactive protein in patients undergoing coronary angiography
Yaron Arbel et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor:: a substudy of the COMMA trial
P Théroux et al.
EUROPEAN HEART JOURNAL (2005)
Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention
HK Yip et al.
CHEST (2005)
C-reactive protein elevation and disease activity in patients with coronary artery disease
R Arroyo-Espliguero et al.
EUROPEAN HEART JOURNAL (2004)
The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty
RJ de Winter et al.
EUROPEAN HEART JOURNAL (2002)
分享论文
